James G. Marken Insider Trading $ANIP ANI PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James G. Marken.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James G. Marken. James G. Marken is SVP Ops & Prod Dev in ANI PHARMACEUTICALS INC ($ANIP) and Vice President, Operations in ANI PHARMACEUTICALS INC ($ANIP).
James G. Marken in ANI PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James G. Marken: SVP Ops & Prod Dev, Vice President, Operations
Holdings: 114,321 shares
Current Value: $7,106,193
Latest Transaction: Apr 13 2021
$ANIP Market Capitalization: $718.77M
$ANIP Previous Close: $62.16
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of James G. Marken in ANI PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 13 2021 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | SVP OPS & PROD DEV | Payment of Exercise | F | 31.86 | 1,878 | 59,833 | 114,321 | 116.2 K to 114.3 K (-1.62 %) |
| Apr 07 2021 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | SVP OPS & PROD DEV | Payment of Exercise | F | 33.69 | 337 | 11,354 | 116,199 | 116.5 K to 116.2 K (-0.29 %) |
| Apr 07 2021 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | SVP OPS & PROD DEV | Payment of Exercise | F | 33.69 | 337 | 11,354 | 116,199 | 116.5 K to 116.2 K (-0.29 %) |
| Mar 31 2021 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | SVP OPS & PROD DEV | Payment of Exercise | F | 36.14 | 278 | 10,047 | 116,536 | 116.8 K to 116.5 K (-0.24 %) |
| Mar 31 2021 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | SVP OPS & PROD DEV | Payment of Exercise | F | 32.68 | 524 | 17,124 | 116,814 | 117.3 K to 116.8 K (-0.45 %) |
| Mar 31 2021 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | SVP OPS & PROD DEV | Payment of Exercise | F | 36.14 | 278 | 10,047 | 116,536 | 116.8 K to 116.5 K (-0.24 %) |
| Mar 31 2021 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | SVP OPS & PROD DEV | Payment of Exercise | F | 32.68 | 524 | 17,124 | 116,814 | 117.3 K to 116.8 K (-0.45 %) |
| Apr 14 2020 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | SVP Ops & Prod Dev | Grant | A | 0.00 | 24,548 | 0 | 85,297 | 60.7 K to 85.3 K (+40.41 %) |
| Apr 08 2020 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | SVP Ops & Prod Dev | Payment of Exercise | F | 43.93 | 144 | 6,326 | 60,749 | 60.9 K to 60.7 K (-0.24 %) |
| Apr 08 2020 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | SVP Ops & Prod Dev | Payment of Exercise | F | 43.22 | 337 | 14,565 | 60,893 | 61.2 K to 60.9 K (-0.55 %) |
| May 20 2019 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | SVP Ops & Prod Dev | Sell | S | 70.67 | 8,907 | 629,458 | 61,230 | 70.1 K to 61.2 K (-12.70 %) |
| Apr 18 2019 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | SVP Ops & Prod Dev | Payment of Exercise | F | 68.60 | 115 | 7,889 | 75,054 | 75.2 K to 75.1 K (-0.15 %) |
| Apr 09 2019 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | SVP Ops & Prod Dev | Payment of Exercise | F | 70.50 | 144 | 10,152 | 75,169 | 75.3 K to 75.2 K (-0.19 %) |
| Apr 09 2019 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | SVP Ops & Prod Dev | Payment of Exercise | F | 70.50 | 337 | 23,759 | 75,313 | 75.7 K to 75.3 K (-0.45 %) |
| Apr 01 2019 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | SVP Ops & Prod Dev | Option Exercise | A | 66.39 | 8,285 | 550,041 | 8,285 | |
| Apr 01 2019 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | SVP Ops & Prod Dev | Grant | A | 0.00 | 6,848 | 0 | 75,928 | 69.1 K to 75.9 K (+9.91 %) |
| May 24 2018 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | SVP Ops & Prod Dev | Payment of Exercise | F | 61.88 | 253 | 15,656 | 69,080 | 69.3 K to 69.1 K (-0.36 %) |
| Apr 18 2018 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | SVP Ops & Prod Dev | Payment of Exercise | F | 60.21 | 115 | 6,924 | 69,333 | 69.4 K to 69.3 K (-0.17 %) |
| Apr 10 2018 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | SVP Ops & Prod Dev | Option Exercise | A | 57.06 | 5,300 | 302,418 | 5,300 | |
| Apr 10 2018 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | SVP Ops & Prod Dev | Payment of Exercise | F | 57.06 | 144 | 8,217 | 69,448 | 69.6 K to 69.4 K (-0.21 %) |
| Apr 10 2018 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | SVP Ops & Prod Dev | Grant | A | 0.00 | 4,400 | 0 | 69,592 | 65.2 K to 69.6 K (+6.75 %) |
| Apr 03 2018 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | SVP Ops & Prod Dev | Payment of Exercise | F | 58.22 | 278 | 16,185 | 65,192 | 65.5 K to 65.2 K (-0.42 %) |
| Mar 07 2018 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | SVP Ops & Prod Dev | Option Exercise | M | 33.00 | 3,208 | 105,864 | 1,667 | |
| Mar 07 2018 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | SVP Ops & Prod Dev | Option Exercise | M | 6.36 | 14,793 | 94,083 | 0 | |
| Mar 07 2018 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | SVP Ops & Prod Dev | Sell | S | 61.92 | 4,177 | 258,640 | 65,470 | 69.6 K to 65.5 K (-6.00 %) |
| Mar 07 2018 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | SVP Ops & Prod Dev | Buy | M | 33.00 | 3,208 | 105,864 | 69,647 | 66.4 K to 69.6 K (+4.83 %) |
| Mar 07 2018 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | SVP Ops & Prod Dev | Buy | M | 6.36 | 14,793 | 94,083 | 66,439 | 51.6 K to 66.4 K (+28.64 %) |
| May 24 2017 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | SVP Ops & Prod Dev | Payment of Exercise | F | 47.01 | 278 | 13,069 | 51,549 | 51.8 K to 51.5 K (-0.54 %) |
| Apr 11 2016 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | Vice President, Ope ... | Option Exercise | A | 40.59 | 3,750 | 152,213 | 3,750 | |
| Apr 11 2016 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | Vice President, Ope ... | Grant | A | 0.00 | 1,875 | 0 | 47,858 | 46 K to 47.9 K (+4.08 %) |
| Dec 22 2015 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | Vice President, Ope ... | Sell | S | 43.26 | 3,500 | 151,410 | 45,983 | 49.5 K to 46 K (-7.07 %) |
| Jul 20 2015 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | Vice President, Ope ... | Option Exercise | M | 6.36 | 7,395 | 47,032 | 14,793 | |
| Jul 20 2015 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | Vice President, Ope ... | Buy | M | 6.36 | 7,395 | 47,032 | 49,483 | 42.1 K to 49.5 K (+17.57 %) |
| May 14 2015 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | Vice President, Ope ... | Option Exercise | M | 33.00 | 1,625 | 53,625 | 4,875 | |
| May 14 2015 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | Vice President, Ope ... | Option Exercise | M | 6.36 | 7,395 | 47,032 | 22,188 | |
| May 14 2015 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | Vice President, Ope ... | Buy | M | 33.00 | 1,625 | 53,625 | 42,088 | 40.5 K to 42.1 K (+4.02 %) |
| May 14 2015 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | Vice President, Ope ... | Buy | M | 6.36 | 7,395 | 47,032 | 40,463 | 33.1 K to 40.5 K (+22.36 %) |
| Apr 20 2015 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | Vice President, Ope ... | Option Exercise | A | 68.71 | 3,000 | 206,130 | 3,000 | |
| Apr 20 2015 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | Vice President, Ope ... | Grant | A | 0.00 | 1,500 | 0 | 33,068 | 31.6 K to 33.1 K (+4.75 %) |
| Mar 19 2015 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | Vice President, Ope ... | Sell | S | 66.50 | 15,000 | 997,500 | 31,568 | 46.6 K to 31.6 K (-32.21 %) |
| Jun 21 2013 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | Vice President, Ope ... | Payment of Exercise | F | 0.00 | 145,629 | 0 | 289,612 | 435.2 K to 289.6 K (-33.46 %) |
| Jun 21 2013 | ANIP | ANI PHARMACEUTICAL ... | Marken James G. | Vice President, Ope ... | Grant | A | 0.00 | 435,241 | 0 | 435,241 | 0 to 435.2 K |
Page: 1